Biogen shareholders elect biotech exec Susan Langer to the board after romantic partner departs
Biogen shareholders have elected Susan Langer to the drugmaker’s board, part of a series of changes to refresh the biotech’s governance.
Langer’s nomination to the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
